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Synthesis of novel trivalent -C-mannosides bearing different end-functionalized tethers is described. 
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1. Introduction 
There are a large number of essential biological processes 
that rely on carbohydrate-mediated recognition events at the cell 
surface. Numerous examples of such events include host cell 
recognition
 
and cancer-mediated processes
1-5
 and many of these 
processes are known to involve the presentation of multivalent 
carbohydrate species, greatly enhancing overall ligand-receptor 
affinities through cooperative binding. As a result of this there is 
a need for robust and efficient syntheses of multivalent 
carbohydrate architectures as a means to provide useful tools for 
studying cluster-glycoside-mediated biological recognition 
processes. This is a rapidly expanding area of glycobiology and 
there are many examples of different synthetic approaches to
6-13
 
and applications of multivalent carbohydrates. There is specific 
importance in synthetic access to new, diverse multivalent 
carbohydrates with useful functional tethers, providing reagents 
for conjugation to labelling agents, immobilization and array 
applications.
14-18 
C-Glycosidic multivalent saccharides provide 
the potential to generate libraries of stereochemically-defined 
multivalent core sections, which can be adapted for a diversity of 
targets through modular syntheses and which are hydrolytically 
and enzymatically stable. There are few examples of multivalent 
C-glycosides, with examples of oxazole linked tri- and 
tetravalent systems
19a
 on a pentaerythritol core, systems based on 
calixarene scaffolds,
19b 
and peptide-spacer linked examples.
19c 
We have previously reported the synthesis of a novel tris-C-
mannoside carboxylate intermediate 1 and its elaboration by 
attachment of a pyrenyl fluorophore.
20
 This letter describes a 
divergent and modular approach to creating end-functionalized 
multivalent ligands through attachment of different 
functionalized groups to 1 (Figure 1).  
Specifically, we report elaboration of trivalent-C-mannoside 
1 with a novel thio-terminated alkyl ether and also a bifunctional 
fluorophore, suitable for further conjugations and/or 
immobilizations exploiting an embedded fluorescent reporter 
group. 
Figure 1. Multivalent C-mannosyl carboxylate 1  
2. Results and discussion 
2.1. Attachment of an extended thio-tether to core trivalent 
C-mannoside 1 
Free thiols and thioethers are well established as suitable 
functional groups for the immobilisation and study of 
biomolecules and ligands, including interesting multivalent 
carbohydrate architectures.
21-23
 There have been a growing 
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number of examples of multivalent carbohydrate ligand 
immobilization using SPR arrays, and several valuable reports of 
attachment to Quantum dots
24
 or gold nanoparticles.
25
 Thus we 
sought to illustrate that trivalent C-mannoside 1 could be 
elaborated with an extended tether bearing a terminal sulfur 
functionality. We sought to demonstrate this using a novel 
extended thiol-terminated unit with lipid-like characteristics 
(Scheme 1). 
Scheme 1. Reagents and conditions: (i) BnSH, NaOH, EtOH, 40 ºC, 
2 d, 69% (ii) BH3.THF, THF, RT, 5 h, 96% (iii) CH2=CHCN, NaH, 
dioxane, RT, 18 h, 89% (iv) BH3.Me2S, THF, reflux, 2 h, 98%. 
 
Thus, S-alkylation of 5-bromovaleric acid with benzyl mercaptan 
gave the desired thioether
26
 and subsequent reduction of the 
carboxylic acid using BH3.THF successfully delivered alcohol 
2.
27
 This material was then extended through O-alkylation with 
acrylonitrile to furnish novel nitrile 3. Finally, reduction of 3 with 
BH3.SMe2 gave novel amine 4 in excellent yield, suitable for 
coupling with multivalent carboxylate 1. Coupling of amine 4 to 
acid 1 efficiently afforded the target trivalent C-mannoside 5,
28
 
bearing the novel thio-tether end group (Scheme 2). 
Scheme 2. Reagents and conditions: (i) TBTU, HOBt, DIPEA, 
DMF, RT, 24 h, 68%. 
 
2.2 Attachment of a bifunctional fluorescent labelling tether 
The second type of multivalent architecture reported 
incorporates a tether which contains an embedded fluorescent tag 
which has two orthogonal functional groups. The interest here lay 
in delivering both the capability for a further divergence to 
heterogeneous multivalent targets, but also for embedding a 
fluorescent label in the linker, whilst retaining reactivity for 
further conjugations without any further functional group 
manipulations. Recently, the utility of simpler monovalent N-
glycans bearing an AEAB-derived unit within a linker has been 
illustrated in applications to generating glycan arrays with 
embedded fluorophores.
18 
Thus, coupling of 3,5-diaminobenzoic acid methyl ester 
(DABME) with trivalent 1 demonstrated that mono-amidation 
could be intercepted (anticipated from the predicted slower 
second amidation with a second large dendron) thus affording the 
target mono-amide derivative 6 (Scheme 3).
29 
Scheme 3. Reagents and conditions: (i) TBTU, HOBt, DIPEA, 
DMF, RT, 24 h, 44%. 
Compound 6 exhibited fluorescence at 380 nm (with 
excitation at 241 nm, Figure 2), thus confirming this novel 
multivalent C-glycoside ligand has an effective embedded 
fluorescent motif. A terminal anilino function is widely 
employed for array synthesis/immobilization or conjugations and 
thus 6 is well suited as a new tool for such applications. 
Additionally, this material could be used further to create more 
elaborate multivalent compounds through manipulation of the 
amino and ester functionalities with suitable pre-formed 
multivalent constructs. For example, the amino group of 6 would 
be suitable for coupling to different carboxylate terminated 
multivalent saccharide modules to provide heterogeneous higher-
valent structures. The aryl ester would also remain available for 
attaching a handle for immobilization once the amino group were 
employed for conjugation, providing potential for double 
reported group attachment. Thus, compound 6 offers potential 
access to novel diversity for applications to arrays of higher 
valent, fluorescently labelled C-glycosidic ligands. 
Figure 2: Fluorescence spectrum for trivalent C-mannoside 6. 
 
 3 
2.4 Addressing individual saccharide valency  
Having demonstrated that DABME could be singly 
conjugated with a larger trivalent mannoside and in order to 
investigate the assembly of more complex/higher valency 
multivalent architectures, we undertook the synthesis of bivalent 
C-glycosidic derivative 9 through amidation of DABME with a 
smaller, monovalent C-glycoside unit (Scheme 4). In this case we 
employed the known C-galactoside monomer 7,
30
 which was 
efficiently di-coupled with DABME to furnish 8 and following 
saponification, yielded the desired acid 9. 
Scheme 4. Reagents and conditions: (i) TBTU, HOBt, DIPEA, 
DMF, RT, 16 h, 57% (ii) NaOH, THF/H2O, RT, 3 h, 72%. 
3. Conclusion  
We report the synthesis of two novel multivalent C-glycosidic 
mannosyl ligands, 5 and 6, whose differing functional tethers 
facilitate future utilisation as probes to investigate multivalent 
carbohydrate interactions. Inclusion of an embedded fluorescent 
label combined with bidirectional further functionalization 
options provides a valuable and versatile tool to explore the 
potential of novel C-glycosidic ligands. 
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11. Ortega-Muñoz, M.; Perez-Balderas, F.; Julia Morales-Sanfrutos, 
J.; Hernandez-Mateo, F.; Isac-Garcia, J.; Santoyo-Gonzalez, F. 
Eur. J. Org. Chem. 2009, 15, 2441–2453. 
12. Srinivas, O.; Radhika, S.; Bandaru, N. M.; Nadimpalli, S. K.; 
Jayaraman, N. Org. Biomol. Chem. 2005, 3, 4252–4257. 
13. Kim, J.; Ahn, Y.; Park, K. M.; Kim, Y.; Ko, Y. H.; Oh, D. H.; 
Kimoon, K. Angew. Chem. Int. Ed. 2007, 46, 7393–7395. 
14. Lindhorst, T. K.; Märten, M; Fuchs, A.; Knight, S. D. Beilstein J. 
Org. Chem. 2010, 6, 810–822. 
15. Pera, N. P.; Branderhorst, H. M.; Kooij, R.; Maierhofer, C.; van 
der Kaaden, M.; Liskamp, R. M. J.; Wittmann, V.; Ruijtenbeek, 
R.; Pieters, R. J. ChemBioChem. 2010, 11, 1896-1904. 
16. Lindhorst, T. K.; Märten, M.; Fuchs, A.; Knight, S. D. Beilsten J. 
Org. Chem. 2010, 6, 810-822. 
17. Khorev, O.; Stokmaier, D.; Schwardt, O.; Cutting, B.: Ernst, B. 
Bioorg. & Med. Chem. 2008, 16, 5216–5231. 
18. Park, S.; Sung, J-W.; Shin, I. Chem. Biol. 2009, 4, 699-701. 
19. (a) Perez-Balderas, F.; Hernandez-Mateo , F.; Francisco Santoyo-
Gonzalez, F. Tetrahedron 2005, 61, 9338-9348. (b) Alessandro 
Dondoni, A.; Kleban, M.; Hu, X.; Marra, A.; Banks, H. D. J. Org. 
Chem. 2002, 67, 4722-4733. (c)  Prabhat Arya P.; Kutterer, K. M. 
K.; Qin, H.; Roby, J.; Barnes, M. L.; Lin, S.; Lingwood, C. A.; 
Peter, M. G. Bioorg. & Med. Chem.  1999, 7, 2823-2833 and 
references therein. 
20. Miller, G. J.; Gardiner, J. M. Org. Lett. 2010, 12, 5262-5265. 
21. Klenkar, G.; Valiokas, R.; Lundstrom, I.; Tinazli, A.; Tampe, R.; 
Piehler, J.; Liedberg, B. Anal. Chem. 2006, 78, 3643-3650. 
22. Lienemann, M.; Paananen, A.; Boer, H.; de la Fuente, J. M.; 
García, I.; Penadés, S.; Koivula, A. Glycobiology, 2009, 19, 633-
643. 
23. Karamanska, R.; Mukhopadhyay, B.; Russell, D. A.; Field, R. A. 
Chem. Commun. 2005, 26, 3334–3336. 
24. (a) Mukhopadhyay, B.; Martins, M. B.; Russell, D. A.; Field, R. 
A. Tetrahedron Lett.  2009, 50, 886-889. (b) Yu, M.; Yang, Y.; 
Han, R.; Zheng, Q.; Wang, L.; Hong, Y.; Ki, Z.; Sha, Y. Langmuir 
2010, 26, 8534-8539. 
25. Chien, Y. Y.; Jan, M. D.; Adak, A. K.; Tzeng, H. C.; Lin, Y. P.; 
Chen, Y. J.; Wang, K. T.; Chen, C. T.; Chen, C. C.; Lin, C. C. 
ChemBioChem 2008, 9, 1100-1109. 
26. Fraefel, W.; Vigneaud, V. J. Am. Chem. Soc. 1970, 92, 1030-
1032. 
27. Eliel, E. L.; Nowak, B. E.; Daignault, R. A. J. Org. Chem. 1965, 
30, 2448-2450. 
28. Selected data for 5: 1H NMR (CDCl3, 300 MHz)  7.33-7.18 (m, 
65H, Ar CH), 7.04 (s, 1H, NH), 6.60 (s, 1H, NH), 6.35 (t, J = 5.4, 
3H, NH), 4.71 (d, J = 11.4, 3H, OCH2Ph), 4.63-4.47 (m, 21H, 
OCH2Ph), 3.98 (td, J = 9.6, 4.7, 3H, H1 sugar), 3.79-3.60 (m, 26H, 
sugar ring + CH2O + PhCH2S), 3.39-3.20 [m, 16H, OCH2 core, 
CH2NHC(O), 2 x CH2O tether], 2.97-3.04 [m, 2H, CH2NHC(O) 
tether], 2.57-2.38 [m, 6H, 2 x CH2C(O)NH + BnSCH2], 2.32-2.20 
[m, 6H, CH2C(O)NH], 1.82-1.87 (m, 6H, CH2 alkyl), 1.76-1.46 
(m, 14H, CH2 alkyl); 
13C NMR (CDCl3, 100 MHz)  173.1 (C=O 
amide), 172.8 (2 x C=O amide), 138.6-138.5 (4 Ar C), 130.4-
127.3 (Ar CH), 77.6 (CH sugar), 76.4 (CH sugar), 75.3 (CH 
sugar), 74.3 (CH2), 73.6 (CH sugar), 73.5 (CH2), 72.5 (CH2), 72.4 
(CH sugar), 72.1 (CH2), 71.2 (CH2 tether), 70.0 (CH2), 69.5 (CH2 
core), 69.3 (CH2, tether), 69.1 (CH2 core), 60.1 (4 C core), 40.5 
[CH2NHC(O)], 37.0 [CH2NHC(O)], 36.7 (PhCH2S), 32.9 
[CH2C(O)], 32.6 (CH2 alkyl), 31.6 (BnSCH2), 30.1 [CH2C(O)], 
30.1 [CH2C(O)], 29.7 [CH2CH2C(O)NH], 29.7 (CH2 alkyl), 29.4 
(CH2 alkyl), 25.9 (CH2 alkyl), 25.9 (CH2 alkyl); MS m/z 2400 
(MNa+, 100%); IR (neat) max 3433, 1654, 1456, 1269, 1102 cm
-1; 
Specific Rotation []26 = + 28.3  (c 0.5, CHCl3). 
29. Selected data for 6: 1H NMR (CDCl3, 300 MHz)  7.53-7.18 (m, 
63H, Ar CH), 6.97 (s, 1H, NH), 6.52 (s, 1H, NH), 6.31 (t, J = 5.7, 
3H, NH), 4.73-4.45 (m, 24H, OCH2Ph), 3.95-4.01 (m, 3H, H1 
sugar), 3.79-3.61 (m, 24H, sugar ring, CH2O, OCH3), 3.37-3.34 (t, 
J = 5.6, 6H, OCH2), 3.23-3.21 [m, 6H, CH2NHC(O)], 2.65-2.48 
[m, 4H, 2 x CH2C(O)NH], 2.32-2.24 [m, 6H, CH2C(O)NH], 1.91-
1.85 (m, 6H, CH2 alkyl), 1.61-1.57 (m, 6H, CH2 alkyl); 
13C NMR 
(CDCl3, 75 MHz)  173.2 (C=O amide), 172.9 (2 x C=O amide), 
171.4 (C=O ester), 140.2 (Ar CH), 138.6-138.5 (4 Ar C), 128.7-
128.1 (Ar CH), 77.6 (CH sugar), 76.6 (CH sugar), 75.4 (CH 
sugar), 74.2 (CH2), 73.6 (CH sugar), 73.6 (CH2), 72.6 (CH2), 72.5 
(CH sugar), 72.2 (CH2), 70.2 (CH2), 69.5 (CH2 core), 69.2 (CH2 
core), 60.0 (4 C core), 52.3 (OCH3), 37.2 [CH2NHC(O)], 33.0 
[CH2C(O)], 30.1 [CH2C(O)], 30.1 [CH2C(O)], 29.8 
[CH2CH2C(O)NH], 25.9 (CH2 alkyl core); MS m/z 2299 (MNa
+, 
100%), 2178 (40%); IR (neat) max 3338, 3089, 3062, 3027, 2929, 
2863, 1723, 1645, 1548, 1450, 1365, 1217, 1096 cm-1; Specific 
Rotation []26 = + 37.7 (c 0.3, CHCl3). 
30. Fletcher, S.; Jorgensen, M. R.; Miller, A. D. Org. Lett. 2004, 6, 
4245-4248. The α-stereoselectivity for the C-allyl precursor of 7 
was first reported by Kishi. Confirmation in our case of the 
selectivity was provided by COSY, NOESY and TOCSY data. 
31. Lewis, M. D.; Cha, J. K.; Kishi, Y. J. Am. Chem. Soc. 1982, 104, 
4976-4978. 
 
 
Supplementary Information 
H2N NH2
O OMe
O
BnO
BnO
BnO
OBn
NH
O
N
H
O
O
BnO
BnO
BnO
OBn
CO2R
O
BnO
BnO
BnO
OBn
R = Me
R = H
iCO2H
ii
Tetrahedron 4 
Experimental details for the synthesis of compounds 3-6, 8 
and 9, details of UV and fluorescence experiments for compound 
6 and copies of 
1
H and 
13
C NMR spectra for compounds 3-6, 8 
and 9 and MS spectra for compounds 5, 6, 8 and 9, and COSY, 
NOESY, TOCSY spectra of the C-allyl precursor of 7, are 
available as supporting information. 
 
 
